Maria Sole Sartini
Overview
Explore the profile of Maria Sole Sartini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Covello G, Maglionico M, Figus M, Busoni C, Sartini M, Lupidi M, et al.
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124798
This prospective study evaluated the impact of anatomical and tomographic biomarkers on clinical outcomes of intravitreal dexamethasone implants in patients with macular edema secondary to retinal vein occlusion (RVO). :...
2.
Loiudice P, Covello G, Figus M, Posarelli C, Sartini M, Casini G
J Clin Med
. 2022 Aug;
11(16).
PMID: 36012996
(1) Background: we aimed to evaluate choroidal vascularity change in eyes with central and branch retinal vein occlusion (RVO). (2) Methods: in this retrospective cross-sectional study, we reviewed the records...
3.
Lazzeri S, Orlandi P, Piaggi P, Sartini M, Casini G, Guidi G, et al.
Pharmacogenomics
. 2015 Dec;
17(1):35-9.
PMID: 26653034
Aim: To investigate possible associations between VEGFR-2 and IL-8 gene SNPs and 1-year response to intravitreal ranibizumab for exudative age-related macular degeneration. Materials & Methods: Sixty-four eyes underwent a loading...
4.
Lazzeri S, Ripandelli G, Sartini M, Parravano M, Varano M, Nardi M, et al.
Angiogenesis
. 2015 Sep;
18(4):397-432.
PMID: 26346237
Purpose: The recent introduction of anti-VEGF drugs has widely changed the prognosis of exudative age-related macular degeneration (AMD), even if a variable percentage of patients showed an insufficient response. Aflibercept...
5.
Lazzeri S, Figus M, Sartini M, Scarinci F, Casini G, Guidi G, et al.
Ophthalmologica
. 2015 Feb;
233(2):74-81.
PMID: 25662794
Purpose: To evaluate the effects of intravitreal ranibizumab monotherapy on predominantly hemorrhagic choroidal neovascularization with foveal involvement associated with age-related macular degeneration. Materials And Methods: Twenty-two consecutive eyes with hemorrhagic...
6.
Lazzeri S, Figus M, Orlandi P, Fioravanti A, Di Desidero T, Agosta E, et al.
Pharmacogenomics
. 2013 Apr;
14(6):623-30.
PMID: 23570466
Aim: To investigate the association between VEGF gene SNPs and early response to intravitreal ranibizumab for exudative age-related macular degeneration. Materials & Methods: Sixty-four patients (64 eyes) were prospectively enrolled...
7.
Lazzeri S, Orlandi P, Figus M, Fioravanti A, Cascio E, Di Desidero T, et al.
ScientificWorldJournal
. 2012 Aug;
2012:420190.
PMID: 22919317
In this prospective, case-control genetic study, 120 consecutive neovascular age-related macular degeneration (AMD) cases and 78 controls were enrolled. Two SNPs (rs2071559 and rs1870377) of VEGF-A receptor-2 (VEGFR-2) gene were...
8.
Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration
Agosta E, Lazzeri S, Orlandi P, Figus M, Fioravanti A, Di Desidero T, et al.
Pharmacogenomics
. 2012 Jul;
13(9):1037-53.
PMID: 22838951
Age-related macular degeneration (AMD), the most common age-related disease causing irreversible visual loss in industrialized countries, is a complex and multifactorial illness. Researchers have found components of the complement alternative...
9.
Marcocci C, Bartalena L, Rocchi R, Marino M, Menconi F, Morabito E, et al.
J Clin Endocrinol Metab
. 2003 Aug;
88(8):3561-6.
PMID: 12915636
We investigated the long-term side-effects of orbital radiotherapy (OR) in 204 patients with Graves' ophthalmopathy (GO), irradiated from 1972-1996 [44 by cobalt unit (CU) and 160 by linear accelerator (LA),...